Trailokya Abhijit, Hiremath J S, Sawhney Jps, Mishra Y K, Kanhere Vivek, Srinivasa R, Tiwaskar Mangesh
Medical Services Division, Abbott Healthcare Private Limited, Mumbai, Maharashtra.
Director, Cath Lab, Ruby Hall Clinic, Pune, Maharashtra.
J Assoc Physicians India. 2016 Feb;64(2):88-93.
Anticoagulant treatment is required for the treatment and prevention of thromboembolic disorders. Vitamin K antagonists are commonly used oral anticoagulants worldwide. Acenocoumarol is mono-coumarin derivative with racemic mixture of R (+) and S (-) enantiomers. Efficacy and safety of acenocoumarol has been evaluated in atrial fibrillation, cardiac valve replacement, after myocardial infarction, treatment of deep vein thrombosis, after major surgeries and after critical illness requiring prolonged hospitalization. Acenocoumarol is effective and safe in all age groups. It offers an advantage over warfarin in terms of better stability of anti-coagulant effect. Due to its economic advantage acenocoumarol may be suitable oral anticoagulant for long term use in countries like India.
治疗和预防血栓栓塞性疾病需要进行抗凝治疗。维生素K拮抗剂是全球常用的口服抗凝剂。醋硝香豆素是一种单香豆素衍生物,具有R(+)和S(-)对映体的外消旋混合物。醋硝香豆素在心房颤动、心脏瓣膜置换、心肌梗死后、深静脉血栓形成的治疗、大手术后以及需要长期住院的危重症后的疗效和安全性已得到评估。醋硝香豆素在所有年龄组中都是有效且安全的。在抗凝效果的稳定性方面,它比华法林更具优势。由于其经济优势,醋硝香豆素可能是印度等国家长期使用的合适口服抗凝剂。